Healthtech Startups

Neurodon develops small-molecule therapeutics that target cellular calcium imbalance and the endoplasmic reticulum stress pathway, using compounds that allosterically modulate the SERCA enzyme to restore calcium transport. Its disease-modifying approach aims at conditions linked to cellular stress such as diabetes, Alzheimer's, Parkinson's, and Duchenne muscular dystrophy.

1 investor

Neurodyn Life Sciences is a biotech incubator that identifies and develops natural bioactives into prescription drugs and natural products for neurological diseases and brain health. It runs preclinical drug programs (including progranulin/granulin therapies for ALS) through its in-house CRO and spins mature projects into standalone or partnered businesses.

1 investor

NeuroEM Therapeutics develops MemorEM, a wearable head device that administers transcranial electromagnetic treatment to treat cognitive decline and Alzheimer's disease. The device targets patients with neurodegenerative diseases through a non-invasive, in-home treatment delivered by healthcare professionals.

1 investor

Neurofit is a web-based cognitive rehabilitation platform that enables clinicians to assign adaptive cognitive activities, track client performance data, and generate clinical reports for insurance claims. It serves occupational therapists, speech-language pathologists, neuropsychologists, and rehabilitation medicine professionals treating clients across the lifespan.

1 investor

NeuroGevity develops a sleep headband with biometric sensors and AI algorithms to assess brain health and detect neurophysiological biomarkers at home. The company also offers sound-based stimulation synchronized to brain activity to enhance slow-wave sleep and memory consolidation.

1 investor

NeuroGenesis develops cell therapies for neurodegenerative diseases, leveraging its NG CELL platform to enhance stem cells for treating conditions like multiple sclerosis and ALS. The company is advancing Phase IIb clinical trials in Europe and Israel with a focus on remyelinating and regenerative cellular medicine.

1 investor

NeuroHive develops digital health monitoring and precision livestock farming tools for farmers, combining veterinary expertise with software engineering to track animal health in real-time.

1 investor

Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain. It serves eye-care patients across all ages through providers, offering Single Vision, Office, and Progressive lens designs.

1 investor

Neurolentech develops therapeutics for neurodevelopmental disorders such as epilepsy, intellectual disability, and severe autism, using patient-derived neuronal cell models to identify druggable targets and accelerate drug discovery. It works with clinicians and patient foundations, including the Tess Foundation, to develop treatments for indications like SLC13A5 epilepsy.

1 investor

Neurolieve is a life-science company developing therapeutics for neuropathic and chronic pain, with expertise in neuroscience, clinical pain medicine and drug development. Its lead program, NLV-01, is built on protein-engineering technology contributed by co-founding partner LifeArc.

1 investor

NeuroRehab VR offers Smart Therapy, a portable VR-based rehabilitation solution for treating upper and lower extremity dysfunction, chronic pain, anxiety, cognition, and balance across orthopedic, neurological, and wellness settings. The platform includes AI-powered documentation features and is designed for clinicians in various care environments.

1 investor

Neuronity develops therapies that enhance immune cell activity in the aging brain to prevent neurodegenerative disease progression. The company targets patients with age-related neurological conditions.

1 investor

NeurOp develops novel pharmaceutical compounds targeting NMDA receptors for the treatment of pain, stroke, subarachnoid hemorrhage, and severe depression. The company's lead candidate, NP10679, is in early-stage clinical development.

1 investor

1 investor

NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.

1 investor

NeuroReserve Inc. is a US consumer nutrition company that develops dietary supplements and food products aimed at supporting long-term brain and cognitive health. Its main product, RELEVATE, is a 17-nutrient softgel-and-capsule regimen formulated around nutrients found in Mediterranean and MIND dietary patterns, alongside offerings such as extra virgin olive oil, creatine and an omega-3 product, guided by a medical and scientific advisory team.

1 investor

NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders. Its Monarch eTNS System is an FDA-cleared, prescription home-use device for treating pediatric ADHD in children ages 7 to 12, with additional programs targeting conditions such as autism spectrum disorder, epilepsy, and depression.</parameter> <parameter name="founders">[]

1 investor

NeuroSky provides biofeedback and biometric assessment solutions that help companies optimize hiring decisions, identify employee training needs, and improve workforce productivity through data-driven insights on cognitive performance and employee capabilities.

1 investor

Neurosom develops a wearable sleep therapy device called Sleep WISP that uses EEG monitoring and AI-driven electrical stimulation to improve deep sleep and reduce dementia risk. The system is designed for at-home use and targets patients seeking cognitive health and disease prevention.

1 investor

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.

1 investor

Neurotone develops auditory training software for hearing loss patients. The platform helps patients improve hearing comprehension through brain-based learning, built on over 20 years of clinical research in hearing care.

1 investor

NeuroTrainer offers a cognitive training system using virtual reality and neuroscience to improve mental performance skills for athletes and students. The platform is designed for coaches and educators to elevate cognitive abilities including focus, decision-making, reaction time, and situational awareness.

1 investor

1 investor

NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.

1 investor